The NDA submission was based on the findings of the CAPItello-291 Phase III trial.
Syncona launches its third gene therapy company to stake a claim in the ophthalm...
Following a December approval, the FDA has now given Ferring Pharmaceuticals cle...
The activators might represent both an outpatient, oral therapy for chronic hear...
The FDA approval was based on the findings obtained from a double-blind multi-ce...
The recommended dose of Quviviq is one 50mg tablet to be taken orally each night.
The new investment will be used to expand the company’s existing active pharmace...
Telehealth company Ro has paused advertising of the obesity drug Wegovy as the d...
“There’s a biological process ongoing that really explains why people are strugg...
The FDA is seeking new suppliers to ease shortages of methotrexate, one of the m...
"Employers who are bearing the full risk of the cost of paying for health insura...
Concerns over the integrity of key data led to major tumult at Laronde, a biotec...
As a result of these coming disputes, trans children and teenagers will be left ...
Novartis said it would purchase Chinook Therapeutics, picking up two drugs for a...
The sudden resignation of Francis deSouza as the CEO of Illumina Sunday represen...
Just two weeks after surviving an activist investor’s attempt to oust him from I...
